Trials / Completed
CompletedNCT01338896
Study to Compare Adhesiveness of Two Different Rotigotine Patch Formulations
A Multicenter, Randomized, Double-blind, Two-way Cross-over Study to Compare the Adhesiveness of Two Different Rotigotine Patch Formulations in Subjects With Parkinson's Disease
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 56 (actual)
- Sponsor
- UCB Pharma · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The primary objective of the study is to compare the adhesiveness of two different patch formulations of rotigotine using patch size 40 cm2, under the assumption that both patch formulations show similar adhesiveness properties.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Rotigotine transdermal patch | 8 mg/24 h, transdermal patch 8 mg/24 h, 2 days |
Timeline
- Start date
- 2011-04-01
- Primary completion
- 2011-05-01
- Completion
- 2011-06-01
- First posted
- 2011-04-20
- Last updated
- 2011-08-30
Locations
16 sites across 3 countries: Austria, Germany, United Kingdom
Source: ClinicalTrials.gov record NCT01338896. Inclusion in this directory is not an endorsement.